Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

RND1 inhibits epithelial-mesenchymal transition and temozolomide resistance of glioblastoma via AKT/GSK3-β pathway

5 Mar 2024

Abstract excerpt

GBM is one of the most malignant tumor in central nervous system. The resistance to temozolomide (TMZ) is inevitable in GBM and the characterization of TMZ resistance seriously hinders clinical treatment. It is worthwhile exploring the underlying mechanism of aggressive invasion and TMZ resistance in GBM treatment. Bioinformatic analysis was used to analyze the association between RND1 and a series of EMT-related...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Metastases and Treatment
Share to Cancer Cells and Metastasis
Share to Glioma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38444223
DOI: 10.1080/15384047.2024.2321770

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

RND1 inhibits epithelial-mesenchymal transition and temozolomide resistance of glioblastoma via AKT/GSK3-β pathwayPMID 38444223Read ↗

MicroRNAs as the pivotal regulators of Temozolomide resistance in glioblastomaSemantic proximity Read ↗

Transmembrane emp24 domain-containing protein 3 promotes the malignant progression of glioma by regulating the ZBTB7A signaling axisSemantic proximity Read ↗

LncRNA NEAT1 promotes malignant phenotypes and TMZ resistance in glioblastoma stem cells by regulating let-7g-5p/MAP3K1 axisSemantic proximity Read ↗

RPL22L1, a Novel Candidate Oncogene Promotes Temozolomide Resistance by Activating STAT3 in GlioblastomaSemantic proximity Read ↗

PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transitionSemantic proximity Read ↗

ZBTB7A suppresses glioblastoma tumorigenesis through the transcriptional repression of EPB41L5Semantic proximity Read ↗

Role of DEPDC1 in Glioblastoma Malignant Phenotype and RadiosensitivitySemantic proximity Read ↗

RND2 attenuates apoptosis and autophagy in glioblastoma cells by targeting p38 MAPK signaling pathwaySemantic proximity Read ↗

ZBTB7A suppresses glioblastoma tumorigenesis through the transcriptional repression of EPB41L5Semantic proximity Read ↗

miR-181d/MALT1 regulatory axis attenuates mesenchymal phenotype through NF-κB pathways in glioblastoma.Semantic proximity Read ↗

Glioblastoma Multiforme Formation and EMT: Role of FoxM1 Transcription FactorSemantic proximity Read ↗

Loss of CD99L2 contributed to temozolomide resistance and glioblastoma tumorigenesis based on Genome-scale CRISPR/Cas9 screeningSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.